HCW Biologics annual revenue
2020
2021
2022
2023
2024
2025
HCW Biologics Revenue Growth & History (HCWB)
HCW Biologics reported $54,232 in revenue for fiscal 2025, a decrease of 97.89% from the previous fiscal year.
View full HCW Biologics company overviewHCW Biologics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $54,232 | −$2.5M | −97.89% |
| 2024 | 2024-12-31 | $2.6M | −$275,002 | −9.68% |
| 2023 | 2023-12-31 | $2.8M | −$3.9M | −57.72% |
| 2022 | 2022-12-31 | $6.7M | $6.7M | — |
| 2021 | 2021-12-31 | $0 | −$4.1M | −100.00% |
| 2020 | 2020-12-31 | $4.1M | — | — |
HCW Biologics quarterly revenue
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $121,730 | $115,180 | +1758.47% |
| Q1 2026 | 2026-03-31 | $6.5M | $6.5M | +128231.69% |
| Q4 2025 | 2025-12-31 | $27,011 | −$367,792 | −93.16% |
| Q3 2025 | 2025-09-30 | $15,606 | −$410,817 | −96.34% |
| Q2 2025 | 2025-06-30 | $6,550 | −$612,304 | −98.94% |
| Q1 2025 | 2025-03-31 | $5,065 | −$1.1M | −99.55% |
| Q4 2024 | 2024-12-31 | $394,803 | −$929,199 | −70.18% |
| Q3 2024 | 2024-09-30 | $426,423 | −$426,679 | −50.02% |
| Q2 2024 | 2024-06-30 | $618,854 | −$3,953 | −0.63% |
| Q1 2024 | 2024-03-31 | $1.1M | $1.1M | +2590.14% |
| Q4 2023 | 2023-12-31 | $1.3M | −$17,518 | −1.31% |
| Q3 2023 | 2023-09-30 | $853,102 | −$955,923 | −52.84% |
| Q2 2023 | 2023-06-30 | $622,807 | $168,807 | +37.18% |
| Q1 2023 | 2023-03-31 | $41,883 | −$3.1M | −98.66% |
| Q4 2022 | 2022-12-31 | $1.3M | $1.3M | — |
| Q3 2022 | 2022-09-30 | $1.8M | $1.8M | — |
| Q2 2022 | 2022-06-30 | $454,000 | $454,000 | — |
| Q1 2022 | 2022-03-31 | $3.1M | $3.1M | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
HCW Biologics revenue growth trends
Over the last five reported fiscal years, revenue declined from $4.1M to $54,232, a compound annual decline of 57.90%. HCW Biologics's latest reported quarter, Q2 2026, generated $121,730 in revenue, an increase of 1758.47% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review HCW Biologics source filings ↗